Dillard'S (DDS) EBITDA (2009 - 2026)

Dillard'S (DDS) has 18 years of EBITDA data on file, last reported at $625.5 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 35.61% year-over-year to $625.5 million; the trailing twelve-month figure through Jan 2026 stood at $2.1 billion (up 9.57% YoY), and the FY2026 full-year result was $145.9 million, down 4.77% from the prior year.
• EBITDA for Q1 2026 stood at $625.5 million, up from $492.4 million in the prior quarter.
• Across five years, EBITDA topped out at $625.5 million in Q1 2026 and bottomed at $191.0 million in Q3 2023.
• The 5-year median for EBITDA is $391.9 million (2024), against an average of $389.8 million.
• The widest annual swing landed in 2023, when EBITDA slumped 54.9%; it then soared 120.1% in 2024.
• A 5-year view of EBITDA shows it stood at $269.4 million in 2022, then declined by 20.15% to $215.1 million in 2023, then surged by 120.1% to $473.4 million in 2024, then grew by 4.02% to $492.4 million in 2025, then increased by 27.03% to $625.5 million in 2026.
• The last three EBITDA figures came in at $625.5 million (Q1 2026), $492.4 million (Q4 2025), and $412.5 million (Q3 2025), per Business Quant data.

Peer Comparison